Summary

The global Nasal Lacrimal Tube Stent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Lacrimal stents are thin tubes that are implanted in patients with narrowed but not completely blocked tear ducts.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Nasal Lacrimal Tube Stent leading manufacturers including Beaver-Visitec International, Kaneka, Bess Medizintechnik GmbH, FCI Ophthalmics, Fruida, Sinopsys Surgical, etc., dominate supply; the top five capture approximately % of global revenue, with Beaver-Visitec International leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Nasal Lacrimal Tube Stent market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Beaver-Visitec International
Kaneka
Bess Medizintechnik GmbH
FCI Ophthalmics
Fruida
Sinopsys Surgical
Segment by Type
Mono Canalicular Stents
Canalicular Stents
Segment by Application
Hospitals
Clinics
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Nasal Lacrimal Tube Stent study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Nasal Lacrimal Tube Stent: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Nasal Lacrimal Tube Stent Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Mono Canalicular Stents
1.2.3 Canalicular Stents
1.3 Market Segmentation by Application
1.3.1 Global Nasal Lacrimal Tube Stent Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nasal Lacrimal Tube Stent Revenue Estimates and Forecasts 2020-2031
2.2 Global Nasal Lacrimal Tube Stent Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Nasal Lacrimal Tube Stent Sales Estimates and Forecasts 2020-2031
2.4 Global Nasal Lacrimal Tube Stent Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Nasal Lacrimal Tube Stent Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Nasal Lacrimal Tube Stent Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Mono Canalicular Stents Market Size by Manufacturers
3.5.2 Canalicular Stents Market Size by Manufacturers
3.6 Global Nasal Lacrimal Tube Stent Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Nasal Lacrimal Tube Stent Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Nasal Lacrimal Tube Stent Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Nasal Lacrimal Tube Stent Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Nasal Lacrimal Tube Stent Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Nasal Lacrimal Tube Stent Sales and Revenue by Type (2020-2031)
6.4 North America Nasal Lacrimal Tube Stent Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Nasal Lacrimal Tube Stent Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Nasal Lacrimal Tube Stent Sales and Revenue by Type (2020-2031)
7.4 Europe Nasal Lacrimal Tube Stent Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Nasal Lacrimal Tube Stent Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Nasal Lacrimal Tube Stent Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Nasal Lacrimal Tube Stent Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Nasal Lacrimal Tube Stent Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Nasal Lacrimal Tube Stent Sales and Revenue by Type (2020-2031)
9.4 Central and South America Nasal Lacrimal Tube Stent Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Nasal Lacrimal Tube Stent Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Nasal Lacrimal Tube Stent Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Nasal Lacrimal Tube Stent Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Nasal Lacrimal Tube Stent Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Beaver-Visitec International
11.1.1 Beaver-Visitec International Corporation Information
11.1.2 Beaver-Visitec International Business Overview
11.1.3 Beaver-Visitec International Nasal Lacrimal Tube Stent Product Models, Descriptions and Specifications
11.1.4 Beaver-Visitec International Nasal Lacrimal Tube Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Beaver-Visitec International Nasal Lacrimal Tube Stent Sales by Product in 2024
11.1.6 Beaver-Visitec International Nasal Lacrimal Tube Stent Sales by Application in 2024
11.1.7 Beaver-Visitec International Nasal Lacrimal Tube Stent Sales by Geographic Area in 2024
11.1.8 Beaver-Visitec International Nasal Lacrimal Tube Stent SWOT Analysis
11.1.9 Beaver-Visitec International Recent Developments
11.2 Kaneka
11.2.1 Kaneka Corporation Information
11.2.2 Kaneka Business Overview
11.2.3 Kaneka Nasal Lacrimal Tube Stent Product Models, Descriptions and Specifications
11.2.4 Kaneka Nasal Lacrimal Tube Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Kaneka Nasal Lacrimal Tube Stent Sales by Product in 2024
11.2.6 Kaneka Nasal Lacrimal Tube Stent Sales by Application in 2024
11.2.7 Kaneka Nasal Lacrimal Tube Stent Sales by Geographic Area in 2024
11.2.8 Kaneka Nasal Lacrimal Tube Stent SWOT Analysis
11.2.9 Kaneka Recent Developments
11.3 Bess Medizintechnik GmbH
11.3.1 Bess Medizintechnik GmbH Corporation Information
11.3.2 Bess Medizintechnik GmbH Business Overview
11.3.3 Bess Medizintechnik GmbH Nasal Lacrimal Tube Stent Product Models, Descriptions and Specifications
11.3.4 Bess Medizintechnik GmbH Nasal Lacrimal Tube Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Bess Medizintechnik GmbH Nasal Lacrimal Tube Stent Sales by Product in 2024
11.3.6 Bess Medizintechnik GmbH Nasal Lacrimal Tube Stent Sales by Application in 2024
11.3.7 Bess Medizintechnik GmbH Nasal Lacrimal Tube Stent Sales by Geographic Area in 2024
11.3.8 Bess Medizintechnik GmbH Nasal Lacrimal Tube Stent SWOT Analysis
11.3.9 Bess Medizintechnik GmbH Recent Developments
11.4 FCI Ophthalmics
11.4.1 FCI Ophthalmics Corporation Information
11.4.2 FCI Ophthalmics Business Overview
11.4.3 FCI Ophthalmics Nasal Lacrimal Tube Stent Product Models, Descriptions and Specifications
11.4.4 FCI Ophthalmics Nasal Lacrimal Tube Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 FCI Ophthalmics Nasal Lacrimal Tube Stent Sales by Product in 2024
11.4.6 FCI Ophthalmics Nasal Lacrimal Tube Stent Sales by Application in 2024
11.4.7 FCI Ophthalmics Nasal Lacrimal Tube Stent Sales by Geographic Area in 2024
11.4.8 FCI Ophthalmics Nasal Lacrimal Tube Stent SWOT Analysis
11.4.9 FCI Ophthalmics Recent Developments
11.5 Fruida
11.5.1 Fruida Corporation Information
11.5.2 Fruida Business Overview
11.5.3 Fruida Nasal Lacrimal Tube Stent Product Models, Descriptions and Specifications
11.5.4 Fruida Nasal Lacrimal Tube Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Fruida Nasal Lacrimal Tube Stent Sales by Product in 2024
11.5.6 Fruida Nasal Lacrimal Tube Stent Sales by Application in 2024
11.5.7 Fruida Nasal Lacrimal Tube Stent Sales by Geographic Area in 2024
11.5.8 Fruida Nasal Lacrimal Tube Stent SWOT Analysis
11.5.9 Fruida Recent Developments
11.6 Sinopsys Surgical
11.6.1 Sinopsys Surgical Corporation Information
11.6.2 Sinopsys Surgical Business Overview
11.6.3 Sinopsys Surgical Nasal Lacrimal Tube Stent Product Models, Descriptions and Specifications
11.6.4 Sinopsys Surgical Nasal Lacrimal Tube Stent Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Sinopsys Surgical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Nasal Lacrimal Tube Stent Industry Chain
12.2 Nasal Lacrimal Tube Stent Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Nasal Lacrimal Tube Stent Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Nasal Lacrimal Tube Stent Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Nasal Lacrimal Tube Stent Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Nasal Lacrimal Tube Stent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details